Print previewVALIDITY EXPIRED personal data approved: 2011. I. 26. Publications |
2010
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2011. I. 26. |
de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I, Gravis G, Bodrogi I, Mackenzie MJ, Shen L, Roessner M, Gupta S, Sartor AO: Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial, Lancet, 2010 Oct 2; 376(9747), pp. 1147-1154 type of document: Journal paper/Study paper impact factor: 30.758 language: English URL |
2009
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2011. I. 26. |
Horti J, Widmark A, Stenzl A, Federico MH, Abratt RP, Sanders N, Pover GM, Bodrogi I: A randomized double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer, Cancer Biother Radiopharm 2009 Apr; 24(2), pp. 175-180 type of document: Journal paper/Article impact factor: 1.443 language: English URL |
2009
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2011. I. 26. |
Mai PL, Chen BE, Trucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Bodrogi I, Geczi L, Olah E, et al.: Younger age-at-diagnosis for familial malignant testicular germ cell tumor, Fam Cancer 2009;8(4), pp. 451-456 type of document: Journal paper/Article impact factor: 2.189 language: English URL |
2008
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2009. III. 11. |
J. Horti, E. Juhasz, Z. Monostori, K. Maeda, S. Eckhardt, I. Bodrogi: Phase I study of TZT-1021, a novel synthetic dolostatin 10 derivavite, for the treatment of patients with non-small cell lung cancer, Cancer Chemother. Pharmacol, pp. 173-180 type of document: Journal paper/Study paper language: English
|
2006
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2009. III. 11. |
K. Bíró, L. Noszek, P. Prekopp, K. Nagyiványi, L. Géczi, I. Gaudi, I. Bodrogi: Characteristics and risk factors of cisplatin induced ototoxicity in testicular cancer patients, detected by distorsion product otoacustic emission, Oncology, pp. 177-184 type of document: Journal paper/Study paper impact factor: 2.252 language: English
|
2003
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2009. III. 11. |
Géczi L., Gomez F., Bak M., Bodrogi I.: The incidence, prognosis, clinical and histological characteristics, treatment and outcome of patients with bilateral germ cell testicular cancer in Hungary, J. Cancer Ress Clin Oncol, pp. 309-315 type of document: Journal paper/Study paper impact factor: 2.162 language: English
|
2001
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2009. III. 11. |
Géczi L., Gomez Z., Horváth Zs., Bak M., Kisbenedek L., Bodrogi I.: Three-year result of the first education and early detection program for testicular cancer in Hungary, Oncology, pp. 228-234 type of document: Journal paper/Study paper impact factor: 3.153 language: English
|
1998
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2009. III. 11. |
Kaye S. B., Mead G., Fossa S., Cullen M., de Wit R., Bodrogi I. et al: Intensive Induction-Sequential Chemotherapy with BOP/VIP-B Compared with Treatment with BEP/EP for poor prognosis metastatic nonseminomatosus germ cell tumor: A Randomized Midecal Research Council/European Organisation for Research and Treatment of Cancer Study, J. Clin. Oncol., pp. 692-701 type of document: Journal paper/Study paper impact factor: 7.878 language: English
|
1988
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2011. I. 26. |
Bodrogi István, Baki M., Sinkovics I., Eckhardt S.: Ifosfamide chemotherapy of metastatic renal cell cancer, Semin Surg Oncol. 1988;4(2), pp. 95-96 type of document: Journal paper/Study paper impact factor: 0.651 language: English URL |
1988
![](https://doktori.hu/img/icon_pub_odt.gif) manual entry, 2009. III. 11. |
Bodrogi I., Baki M., Horti J., Liszka Gy., Ottó Sz., Hindy I., Sugár J., Eckhardt S., Karlinger K.: Nem seminoma típusú metasztatikus inoperabilis heredaganatok Vinblastin-Cisplatin-Bleomycin kezelése, Magyar Onkológia, pp. 258-268 type of document: Journal paper/Study paper language: Hungarian
|
| Number of independent citations to these publications: | 0 ![manual entry](https://doktori.hu/img/icon_pub_odt.gif) |
|
|